To receive your instant CME/CE certificate, you must first "Sign In" or "Sign Up" in the top right corner.
RELEASE DATE: November 23, 2020
EXPIRATION DATE: November 30, 2021
MAXIMUM CREDITS: 1.0 AMA PRA Category 1 Credit™ or 1.0 COPE CE credit
CLICK HERE TO PROCEED TO PROGRAM
LEARNING METHOD AND MEDIUM
This educational activity consists of a webcast and ten (10) study questions. The participant should, in order, read the learning objectives, complete the pretest, view the webcast, answer all questions in the posttest, and complete the evaluation. To receive credit for this activity, please complete the posttest and evaluation. This educational activity should take a maximum of 1.0 hour to complete.
ACTIVITY DESCRIPTION AND PURPOSE
Blepharoptosis is drooping of the upper eyelid margin with the eye in primary gaze that has either a congenital or acquired etiology. It is estimated that 12% of adults aged > 50 years have some form of blepharoptosis. Surgery in the form of blepharoplasty has been the standard of care, but with it comes limitations due to skill, cost, and complications. Surgery is also limited to those with medical degrees—typically ophthalmologists and ocular plastic surgeons—which leaves optometrists outside of the realm of being able to provide treatment to their patients. A first-in-class, ophthalmic topical solution has recently been approved to treat acquired forms of adult blepharoptosis and has the potential to change practice behavior and provide a nonsurgical approach to improve the outcomes of patients with acquired blepharoptosis.
INSTRUCTIONS FOR OBTAINING CREDIT
To obtain CME/CE credit for this activity, please view the webcast, consult referenced sources as necessary, and complete the posttest and evaluation online. Upon passing with a score of 70% or higher, a certificate will be made available immediately.
This continuing medical education activity is provided by MedEdicus LLC.
COPE approved for 1.0 CE credit for optometrists.
COPE Course ID: 69548-AS (Interactive Distance Learning Course)
COPE Course Category: Treatment & Management of Ocular Disease: Anterior Segment (AS)
This continuing medical education activity is supported through an unrestricted educational grant from RVL Pharmaceuticals, Inc.
PROCEED TO PROGRAM